DEPARTMENT OF Pathology
|
|
- Calvin Robbins
- 5 years ago
- Views:
Transcription
1 Pathology underlies all of medicine. By examining changes in tissues, blood, DNA, and other specimens, pathologists study the ways in which diseases affect the body. Thus Pathology provides a foundation for every aspect of healthcare and biomedical research, from diagnostic testing and monitoring of chronic diseases, including cancer, to blood transfusion technologies. i
2 rising to the challenge A Call to Action Rising to the Challenge: The Campaign for Johns Hopkins will raise unprecedented levels of support to attract, sustain, and further empower the people of Johns Hopkins our students, faculty, and researchers who through their work improve the lives of millions around the world. Together with our philanthropic partners we will: Advance Discovery and Creativity through support of our exceptional faculty and researchers. Their innovative work drives the development of new knowledge, new forms of expression, and new ways to save lives and improve health, and furthers progress across our core disciplines in science and technology, the humanities and arts, and public health and medicine. Enrich the Student Experience by investing in scholarships and fellowships, inspirational spaces for collaborative learning and social opportunities, and new programs that will enhance studentfaculty interactions, ensure diversity on campus, link learning in the classroom to life after graduation, and strengthen connections between our students and our surrounding communities. Solve Global Problems as One University by creating new cross- disciplinary solutions in crucial areas such as sustaining global water resources, revitalizing America s cities, advancing individualized health, understanding how we learn and teach, and attacking the root causes of global health problems. Department of Pathology is committed to playing a key role in the success of the campaign. Please join with us in this important mission. v At Johns Hopkins University, the Department of Pathology is one of the largest departments in the School of Medicine. Our clinical reach is extensive. Nearly all of the pathology laboratory testing for Johns Hopkins patients is conducted within the Department, which also provides oversight for the approximately 12,871,000 pathology tests performed annually throughout the Hopkins healthcare system at six hospitals and 30 outpatient facilities. Education is a core purpose of the Department of Pathology. Through teaching, mentoring, and formal training programs, the Department educates medical students, residents, fellows, and graduate students. We offer residency programs in anatomic pathology, clinical pathology, and both combined, as well as 16 post-residency fellowship training programs. Research is the Department s signature strength. Multidisciplinary collaboration, incorporation of genomic/ proteomic studies, and moving discoveries from bench to bedside characterize the research efforts at Johns Hopkins. The Department of Pathology is recognized as a research powerhouse in the fields of cancer, infectious diseases, neurodegenerative diseases, and immunology; productive ongoing research targets for Alzheimer s disease, HIV prevention and treatment, parasitology, cell-mediated immunity, leukemia, and pancreatic, colon, breast, ovarian, and cervical cancer. All Pathology faculty actively engage in research. At any given time, there are more than 70 active grants and contracts through the National Institutes of Health (NIH). The Department leads major clinical trial research programs in pathology in Uganda and China, involving 350 investigators and staff. The domain of Pathology is vast, but our approach is highly targeted. The Department focuses intensively on diseases in which they can exert maximal impact in terms of advancing scientific understanding of disease, and generating new knowledge that leads to better patient care. The Department of Pathology At A Glance 115 full-time faculty 110 fellows 34 residents 45 graduate students 1,200 staff employees Ovarian cancer: the silent killer Approximately 22,000 women are diagnosed with ovarian cancer in the United States each year, and annually, 13,580 women die from the disease. Ovarian cancer is known as the silent killer because most women with ovarian cancer are not diagnosed until after the cancer has spread, and is no longer curable. Seventy-five to eighty percent of all ovarian cancer patients are diagnosed with advanced stage disease at initial presentation; the cancer type responsible for 90% of ovarian cancer deaths, high-grade serous carcinoma of the ovary, is confined to the ovary at diagnosis in less than 1% of cases. 1
3 rising to the challenge Despite these grim statistics, there is substantial hope. Faculty in the Department of Pathology have made a startling discovery: the earliest changes in ovarian cancer development occur not in the ovary but in the fallopian tube. Based on cutting-edge genetic research, this fundamental advance in our understanding of ovarian cancer can form the basis for new approaches to prevent the disease, and new tests for detecting it early in time to manage or treat it successfully. Using results from genetic studies, the ovarian cancer team developed a new and now widely-accepted model of the progression of ovarian cancer. The model describes a role for different cell types, each of which responds to a different chemotherapy. This specificity has led to an entirely new approach to ovarian cancer treatment. Future research will use this model, together with knowledge of the tubal origin of many ovarian cancers, to develop more effective prevention and treatment strategies. Funded by an NIH Specialized Program of Research Excellence (SPORE) grant on cervical cancer, Johns Hopkins Pathology investigators developed a vaccine to treat cervical cancer. They are now applying a similar cancer vaccine approach to ovarian cancer, in pursuit of an effective vaccine for this deadly disease. To create an optimal environment conducive to these sorts of research breakthrough, and to translate discoveries into new and improved methods of patient care, we propose to create an Ovarian Cancer Research Center. Building upon the Department s clinical and research strengths, this Center will engage existing faculty and recruit new faculty, physician-scientists devoted to clinical trials of innovative prevention regimens and novel therapies in ovarian cancer. The Center s collaborative research will involve faculty in other Johns Hopkins departments such as Oncology, Gynecology, and Radiation Oncology. The infrastructure it provides, and the large numbers of new patients it will attract to Johns Hopkins, will position the Center to become the country s leader in ovarian cancer research and treatment. The result will be new hope for thousands of ovarian cancer patients each year. Brain cancer: Non-surgical approaches are, all too often, the only hope More than 66,000 new cases of primary brain and central nervous system tumors are diagnosed in the United States each year; approximately 23,000 of these are malignant, killing over 13,000 patients. Brain tumors are a leading cause of childhood cancer deaths. Because of their location and infiltrative behavior, brain tumors usually cannot be fully removed by surgery. Even low-grade tumors in the brain therefore can cause significant, sometimes debilitating symptoms. High-grade tumors are almost always fatal; for malignant brain tumors, little progress has been made in developing effective new therapies. The average survival after diagnosis with one of these tumors is less than two years. New methods of prevention, detection, and treatment are desperately needed. In the Department of Pathology, research is focused on identifying the molecular changes which drive the formation and growth of brain tumors; with this understanding, they are developing new therapies which target these changes. They have already found that treatment-resistant cancer stem cells progress along the same molecular pathways as normal fetal brain cells. This knowledge allowed the Department of Pathology to identify drugs that target the relevant pathways, to destroy the cancer-producing stem cells. To encourage rapid progress in brain tumor research, the Department of Pathology proposes to create a Brain Cancer Research Center. The Center will unite current Pathology faculty, newly recruited physician-scientists devoted to translational brain cancer research, and faculty in the Departments of Oncology, Neurology, Neurosurgery, Radiology, and Radiation Oncology. Teams of scientists will use the latest technologies and research approaches, such as cutting-edge sequencing of large numbers of tumors, to make major discoveries and then, based on these discoveries, to develop effective treatments. Traumatic brain injury: alarmingly little public awareness, despite near-epidemic proportions Traumatic brain injury is the leading cause of death and disability for individuals from ages one to 44. There are about 1.7 million new cases of traumatic brain injury in the United States every year, most of them from motor vehicle accidents or falls. Although many of these cases are concussions causing minor, transitory, or no change in mental status and symptoms, a substantial number lead to chronic disability because of permanent damage or, in some cases, to progressive disease. Motor vehicles and falls are not the only risks to the brain. Repeat concussions among football players and other athletes may result in chronic traumatic encephalopathy very similar to the dementia pugilistica seen in boxers. The Iraq and Afghanistan wars have exposed some 230,000 soldiers to traumatic brain injury, often related to explosion from mines or intermittent explosive devices; blast injury to the brain has become the signature medical problem of these wars. Traumatic brain injury can have both short- and long-term effects; recent evidence suggests that traumatic brain injury places individuals at greater risk for neurological diseases such as Alzheimer s disease and Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig s Disease). We propose to create a Traumatic Brain Injury Center. The goal of the Center will be to define the pathology of traumatic brain injury, develop novel animal and cell models of the traumatic brain injury process, and use these models to discover and test effective new therapies such as small organic compounds, trophic factors, and stem cells. The Center will collaborate closely with the Brain Injury Program in the Bloomberg School of Public Health, the Departments of Neurology, Anesthesiology and Critical Care Medicine, Physical Medicine and Rehabilitation, and Ophthalmology, and the Applied Physics Lab at Johns Hopkins University; the Armed Forces Institute of Pathology; the Department of Neurosurgery at Virginia Commonwealth University; the University of Glasgow Institute of Neurological Sciences, and the traumatic brain injury community locally, nationally, and internationally. The Traumatic Brain Injury Center will build upon substantial strength here at Johns Hopkins. Within the Department, the Division of Neuropathology has studied tissues from multiple neurological disorders, and has played a central role in developing innovative models of neurological disease. These models are helping advance new drug and cellular therapies. Recently, the Division made pioneering observations about the molecular and cellular mechanisms of brain injury and repair. Working with both human tissue and animal models, faculty have begun to develop innovative therapies. The support of a Center devoted to this critical area of research will powerfully expedite the research, and will facilitate its translation into methods of brain protection, preservation, and recovery for hundreds of thousands of individuals who, each year, suffer a traumatic brain injury. An estimated 2 to 4 million high school and college students play collision and contact sports, often more aggressively than professional players. The danger entailed was brought into stark light by the death of a Penn football player and team captain, Owen Thomas. In 2010, at age 21, Owen Thomas committed suicide. Detailed autopsy of his brain showed the early stages of CTE, which has been linked to depression and impulse control. The evidence of CTE in Thomas brain shocked and befuddled a scientific community raised in the doctrine that such neuropathologies are associated with advanced age. 2 3
4 rising to the challenge Why Johns Hopkins? On multiple disease fronts, the Department of Pathology at Johns Hopkins is ideally prepared to generate new knowledge leading to improved methods of diagnosis and treatment. A critical mass of collaborating researchers have been assembled, many of whom are leaders in their field. The Department has the leading cancer genome sequencing team in the world; this is of vital importance in ovarian and brain cancers, which are fundamentally genetic diseases caused by damage to the DNA. Likewise, due to their clinical involvement in analyzing and describing brain tumors resected from patients, the neuropathology team is optimally positioned to lead efforts aimed at developing models to underlie innovative therapies. With the best minds in Pathology assembled, key resources can be leveraged. The Department receives more funding from the NIH than any other pathology department in the world. Our core facilities define the state of the science. Nowhere is there better capacity for pathology research than at Johns Hopkins. The Department of Pathology is fully mobilized, with infrastructure and research teams in place, to use new funds to rapidly advance research agendas. Having made substantial progress in targeted areas, the scientists who are on the cusp of discovery, are poised to make major breakthroughs. With each new discovery, they are committed to translation dedicated to taking new understanding and using it to help people. By applying new knowledge in the real world of medical care, the scientists can envision, design, test, develop, and disseminate new treatments. In this way, the Department of Pathology is determined to make a significant difference, to improve the health and the lives of patients at Johns Hopkins and worldwide. Philanthropy: the critical success factor While the Department of Pathology may seem well funded, in reality the current research economy provides a severe challenge. Research grants have become increasingly competitive. The success rate for grants submitted to the NIH hit an all-time low of 17% in 2011, down dramatically from 32% in To secure federal grants, our faculty must spend more and more time seeking grant opportunities and writing proposals, all of which directly subtracts from their time available for science. Philanthropic funds are a lifesustaining infusion to pathology research, providing vital resources and the scientific freedom to move forward with innovative ideas. Ovarian cancer, brain cancer, and traumatic brain injury are immediate and compelling areas in which Pathology can make a difference. Philanthropy can provide the fuel to propel major progress against these diseases. With numerous health challenges now confronting individuals and society, philanthropic support has never been more essential than it is today, nor has the potential return on investment been more dramatic. At Johns Hopkins, we have the technologies, ideas, momentum, and people necessary for innovation to overcome major challenges to health and wellness. Philanthropy has the power to catalyze transformative work. It is our hope for the future. WHAT WILL IT TAKE? Priority Specific Funding needs Current Use Endowment Funds needed Women s Reproductive Research Core Ovarian Cancer Research Center Brain Cancer Research Center Traumatic Brain Injury Center Research $8,000,000 $2,300,000 $10,300,000 Faculty $4,000,000 $1,800,000 $5,800,000 Education $1,000,000 $200,000 $1,200,000 Research $550,000 $2,000,000 $2,550,000 Faculty: Endowed Professor of Gynecology Oncology Education: Training young physicianscientists in ovarian cancer research $400,000 $2,000,000 $2,400,000 $50,000 $1,000,000 $1,050,000 Ovarian Cancer Clinical Trials Center $2,000,000 $2,000,000 Ovarian Cancer Proteomics $500,000 $2,000,000 $2,500,000 Preclinical Trial Program $200,000 $1,000,000 $1,200,000 Faculty: Center Director, junior faculty $100,000 $3,000,000 $3,100,000 Education: research fellow, invited speaker program $200,000 $1,000,000 $1,200,000 Research: tissue and models core $100,000 $2,000,000 $2,100,000 Research: molecular analysis $200,000 $2,000,000 $2,200,000 Research: development of therapies $200,000 $2,000,000 $2,200,000 Research: cancer stem cells $200,000 $2,000,000 $2,200,000 Faculty: Center Director, junior faculty $100,000 $3,000,000 $3,100,000 Fellowship $100,000 $1,000,000 $1,100,000 Microscope $100,000 $100,000 Research: clinical/pathological $200,000 $2,000,000 $2,200,000 Research: animal model $200,000 $2,000,000 $2,200,000 Research: stem cell therapies $200,000 $2,000,000 $2,200,000 Research: pilot projects $100,000 $2,000,000 $2,100,000 Total $16,700,000 $38,300,000 $55,000,000 1 Kaiser J. NIH grant success rate likely hit historic low in ScienceInsider October 7, Accessed February 20, 2012 at 4 5
5 Rising to the Challenge: The Campaign for Johns Hopkins Department of Pathology Johns Hopkins Medicine 100 North Charles Street, Suite 316 Baltimore, Maryland rev. 03/03/14 6
The Johns Hopkins. the consequences of brain injuries from stroke, traumatic brain injury, or infection.
The nervous system (consisting of the brain, spinal cord, and peripheral nerves) is dauntingly complex and, unfortunately, susceptible to many devastating disorders. Some neurologic diseases and disorders
More informationa case to support THE HEART & VASCULAR CENTER
a case to support THE HEART & VASCULAR CENTER facing TODAY S CHALLENGES Despite remarkable progress in prevention and treatment, cardiovascular diseases including heart attack, stroke, and peripheral vascular
More informationThe Johns Hopkins department of gynecology and obstetrics
The Johns Hopkins department of gynecology and obstetrics A deluge of health information, much of it confusing or conflicting, is directed at women in the United States today. Not surprisingly, women have
More informationWith your help, our goal is to protect millions more against serious illness through the development of new vaccines and other preventions.
Millions of children are alive, healthy, and have grown to productive adulthood because of what our scientists have taught the world through research. The Hib vaccine alone has saved more than 660,000
More informationUC San Diego HIV Institute Creating a Future Without HIV/AIDS
UC San Diego HIV Institute Creating a Future Without HIV/AIDS Executive Summary HIV/AIDS will never cure itself, but at the University of California San Diego and UC San Diego Health, we believe that we
More informationThomas C. Wilmot, Sr. Judy Wilmot Linehan
Thomas C. Wilmot, Sr. Judy Wilmot Linehan The Wilmot Family For more than 35 years, the Wilmot family has been dedicated to supporting cancer research and care for the Rochester community. Their generosity
More informationAUSTRALIA'S ONLY DEDICATED ACADEMIC DEPARTMENT OF NEUROSCIENCE.
AUSTRALIA'S ONLY DEDICATED ACADEMIC DEPARTMENT OF NEUROSCIENCE www.monash.edu/medicine/ccs/neuroscience Ocular motor testing is important as an overall measure of brain function 2 MONASH UNIVERSITY DEPARTMENT
More informationUniversity of Cincinnati Heart, Lung & Vascular Institute
University of Cincinnati Heart, Lung & Vascular Institute The nucleus for research and discovery, patient-centered clinical care and academic excellence. University of Cincinnati Heart, Lung & Vascular
More informationVISION» FOCUS DISCOVERY» CREATION
The Women s Health Research Institute at Northwestern University is turning possibility into reality. The possibility that we can improve women s health by requiring that all research studies put greater
More informationTHE CANADA-ISRAEL TRANS-ATLANTIC COLLABORATION FOR BRAIN STUDIES
DISCUSSION PAPER THE CANADA-ISRAEL TRANS-ATLANTIC COLLABORATION FOR BRAIN STUDIES A Collaborative Research Partnership between Dalhousie University and Ben-Gurion University of the Negev WHERE BREAKTHROUGHS
More informationExcellence Without Exception
Excellence Without Exception The Eastman Institute for Oral Health (EIOH) at the University of Rochester is unique among academic health centers in the United States. Despite the absence of an undergraduate
More informationA World Free From Cancer. BC Cancer Foundation 2011 Report to Donors
A World Free From Cancer BC Cancer Foundation 2011 Report to Donors For the year ended March 31, 2011 Table of Contents Page 3 Page 5 Partners in Discovery A Message from the BC Cancer Foundation Chairman
More informationUCSF Osher Center for Integrative Medicine. Your life, your health, your choice.
UCSF Osher Center for Integrative Medicine Your life, your health, your choice. , ").,\......" 4 Healthcare, the curable crisis. Our nation s healthcare system is in a state of crisis and it affects us
More informationA Blueprint for Breast Cancer Deadline 2020
A Blueprint for Breast Cancer Deadline 2020 In 1991, the National Breast Cancer Coalition was formed with one mission: an end to breast cancer. NBCC has accomplished much over its twenty plus years: bringing
More informationParkinson s Research and the New Centre for Brain Health at UBC. Case for Support The University of British Columbia Faculty of Medicine
Parkinson s Research and the New Centre for Brain Health at UBC Case for Support The University of British Columbia Faculty of Medicine THE VALUE OF A HEALTHY BRAIN By 2020, brain disease will overtake
More informationTranslating Duke Health. Accelerating discovery and its translation
Translating Duke Health Accelerating discovery and its translation Translating Duke Health Biomedical discovery is accelerating innovative and revolutionary advancements in our understanding of human biology,
More informationAn update on your support of the Kaplan Cancer Research Fund Swedish Cancer Institute
An update on your support of the Swedish Cancer Institute At Swedish, we re committed to offering our patients the newest, most innovative cancer treatment available. Through your support of the at the
More informationSustain and Seize Cancer Research Opportunities
One Voice Against Cancer (OVAC) appreciates the opportunity to submit written comments for the record regarding funding for cancer programs for research, prevention, detection, and treatment as well as
More informationResearch For the Future. Len Lichtenfeld, MD, MACP Interim Chief Medical and Scientific Officer
Research For the Future Len Lichtenfeld, MD, MACP Interim Chief Medical and Scientific Officer 1 2 ATTACKING CANCER FROM EVERY ANGLE 3 CANCER PREVENTION STUDIES (CPS) Intramural Research Smoking Obesity
More informationMoorfields Eye Charity Strategy People's sight matters
Moorfields Eye Charity Strategy 2018-2024 People's sight matters Welcome to the strategy for Moorfields Eye Charity 2018-2024 Our strategy builds on the Vision of Excellence strategy from Moorfields Eye
More informationResearch. A Reason for Hope.
Research. A Reason for Hope. Pediatric hydrocephalus alone represents 40,000 annual hospital admissions, 2 433,000 hospital days and $2B worth of hospital charges. 3 Today s Reality Hydrocephalus (h dr
More informationStrategic Plan
Strategic Plan 2013-2018 Strategic Plan 2013-2018 Contents The Challenges of an Aging Population.. Baycrest: fulfilling a legacy of commitment and accomplishment Looking Ahead: dedicated to serve our local
More informationWorld Premier International Research Center (WPI) Initiative General Comments on FY2007 WPI Project Progress by Program Committee
World Premier International Research Center (WPI) Initiative General Comments on FY2007 WPI Project Progress by Program Committee WPI Research Centers In October 2007, the Ministry of Education, Culture,
More informationStrategic Vision. Transforming Health Care
125 125 140 180 86 86 120 178 90 170 2017-2022 Strategic Vision Strategic Vision We are leaders shaping the future of health care. The USC Strategic Vision calls for the university community to address
More informationINDIANA UNIVERSITY SCHOOL OF PUBLIC HEALTH BLOOMINGTON
INDIANA UNIVERSITY SCHOOL OF PUBLIC HEALTH BLOOMINGTON OR ALL WHO NVISION A EALTHIER ORLD At the Indiana University School of Public Health Bloomington, we are building on our university s longstanding
More informationParkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist and Movement Disorders Specialist as Chief Medical Officer
Press Release For Immediate Release October 30, 2017 Contact: Chris Di Salvo Mobile: (408) 506-0455 E-mail: profeff@aol.com Parkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist
More informationUCSF Pulmonary Critical Care Allergy and Sleep Medicine Division. Case for Support
UCSF Pulmonary Critical Care Allergy and Sleep Medicine Division Case for Support Nothing is more basic to human life than breathing. Diseases that impact individuals ability to perform this vital function
More informationChildren s Research Institute
Children s Research Institute Children s National Health System Learning that a child has a serious health condition is devastating. Yet, no matter how dire a diagnosis may be, parents hold out hope that
More informationCivitan International Research Center Achievements
Civitan International Research Center Achievements Autism. Cerebral palsy. Rett syndrome. These are not just words. For millions of families, developmental disabilities are a daily reality. 2 Modern science
More informationMemory Research Suite
Memory Research Suite http://alz.health.usf.edu (813) 396-0606...until Alzheimer s is a memory On The Road to Curing Alzheimer s The Quest for Answers The next big breakthroughs in treating Alzheimer s
More informationUNRAVELING THE MYSTERY BEHIND HIV/AIDS
PRESS RELEASE 3 MAR 2010 UNRAVELING THE MYSTERY BEHIND HIV/AIDS New findings by Nobel Laureate shed light on the elusive AIDS virus and may lead to effective HIV vaccine development 1. Professor Francoise
More informationAgenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK
Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK 1. Introduction 1.1. Alzheimer s Research UK is the UK s leading dementia research charity. As research experts,
More informationCELEBRATING 169 YEARS OF TRADITION AND TRANSFORMATION IN HEALTHCARE RESEARCH
CELEBRATING 169 YEARS OF TRADITION AND TRANSFORMATION IN HEALTHCARE RESEARCH Our MISSION Building on our tradition Reaching out to the community Doing our best to serve, care and heal Together, we aim
More informationINTERVIEW / GEORGE COUKOS. / κεντρικό πρόσωπο
10 INTERVIEW / GEORGE COUKOS MD, PhD, Director of the Department of Oncology at the University Hospital of Lausanne (CHUV), Director of the Lausanne Branch of the Ludwig Institute for Cancer Research,
More informationSTRATEGIC PLAN
STRATEGIC PLAN 2016 2020 Promoting and supporting excellence in research www.immunology.org BSI STRATEGY 2016 2020 EXECUTIVE SUMMARY OUR MISSION Our mission is to promote excellence in immunological research,
More informationVA Funding Opportunities & Research Resources
VA Funding Opportunities & Research Resources Frederick G. Hamel, Ph.D. Acting Associate Chief of Staff/Research Professor Internal Medicine and Pharmacology/ UNMC October 19, 2015 NWI Way Contacts If
More informationAUSTRALIA S FIRST DEDICATED DEPARTMENT OF DIABETES. med.monash.edu/cecs/diabetes
AUSTRALIA S FIRST DEDICATED DEPARTMENT OF DIABETES med.monash.edu/cecs/diabetes 2 MONASH UNIVERSITY DEPARTMENT OF DIABETES AT A GLANCE FAST FACTS WHO WE ARE Monash University s Department of Diabetes is
More informationTestimony of Robert Egge, Vice President of Public Policy Alzheimer s Association. December 8, 2010
U.S. Senate Special Committee on Aging Until There s A Cure: How to Help Alzheimer s Patients and Families NOW Testimony of Robert Egge, Vice President of Public Policy Alzheimer s Association December
More informationNeurofibromatosis (NF) Center
Washington University Neurofibromatosis (NF) Center THE NF CENTER: EXCEPTIONAL CARE THROUGH GROUNDBREAKING RESEARCH An international leader in research and treatment of neurofibromatosis (NF), the Washington
More informationStraight From the Doctors
The world of health is never at a loss for important, cutting-edge topics. So, we let four highly respected Valley doctors hold the writing reins, asking them to explain what they believe is a leading
More informationMembership Information and Application
Membership Information and Application Mission Statement The mission of the American Society of Neurorehabilitation (ASNR) is to promote the medical and social wellbeing of persons with disabling neurological
More informationPROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund
PROGRESS UPDATE Evan T. Mandeville DIPG Research Fund October 2017 EXECUTIVE SUMMARY Investigators at Dana-Farber Cancer Institute are global leaders in pediatric brain tumor research and patient care,
More informationLEADERSHIP PROFILE. CURE Childhood Cancer believes that childhood cancer can be cured in our lifetime. -- CURE Childhood Cancer s Vision
LEADERSHIP PROFILE CURE Childhood Cancer Atlanta, Georgia CURE Childhood Cancer believes that childhood cancer can be cured in our lifetime. -- CURE Childhood Cancer s Vision THE OPPORTUNITY This is a
More informationResearch goal is to identify better diagnostic, vaccine and treatment targets for chlamydia and gonorrhea
FOR IMMEDIATE RELEASE Contact: Chris Hardwick SOM Office of Public Affairs 410-706-5260 UNIVERSITY OF MARYLAND SCHOOLS OF DENTISTRY AND MEDICINE RECEIVE $10.7M GRANT TO CONDUCT SYSTEMS BIOLOGY RESEARCH
More informationDEPARTMENT OF ONCOLOGY STRATEGIC PLANNING SURVEY THEMES
DEPARTMENT OF ONCOLOGY STRATEGIC PLANNING SURVEY THEMES Vision Concepts: Department of Oncology Lead in generating, applying and transmitting knowledge to enable and advance personalized cancer care Personalized
More informationDefeat Dementia. Five years and 100m of investment to power transformational patient benefit
Defeat Dementia Five years and 100m of investment to power transformational patient benefit An ambition to solve our greatest medical challenge Dementia is our greatest medical challenge. There is currently
More informationREPORT. A Model Clinical Trials System for the 21st Century
www.georgiacore.org www.georgiacancertrials.org REPORT A Model Clinical Trials System for the 21st Century A Response to the Institute of Medicine s 2010 Report A National Cancer Clinical Trials System
More informationThe Lung Cancer Network: Collaborate to Cure
The Lung Cancer Network: Collaborate to Cure The Gala Wednesday, June 6, 2018 Opportunities for Support Everything You Need to Know About the 2018 Gala World-class collaboration. Join us on June 6, 2018
More informationUK Department for International Development: Joining forces in the development of new prevention technologies
Speech [Note: Check against delivery] UK Department for International Development: Joining forces in the development of new prevention technologies Challenges in combating the HIV epidemic, combination
More information$884,000 to Melanoma Research
$884,000 to Melanoma Research EVERY DOLLAR IN GOES OUT! The Miller family funds all event and foundation costs so that every dollar raised goes directly to research and is 100% tax deductible. $734,000
More informationSparrow Cancer Center Updated Naming Opportunities
Sparrow Cancer Center Updated Naming Opportunities $5,000,000 Sparrow Plaza Building This new four-story building, located centrally on the Sparrow Campus, will create a home for an expanded Cancer Center
More informationResearch Strategic Plan
Research Strategic Plan 2016-2021 VISION TO BE AN INTERNATIONAL LEADER IN THE STUDY AND ADVANCEMENT OF HUMAN MOVEMENT, SPORT, HEALTH, AND WELLNESS. MISSION TO PROVIDE EXCELLENCE IN RESEARCH, EDUCATION,
More informationPSYCHIATRY. THE POWER OFx. Experts. Experience. Execution. A Deeper Dive into Psychiatry. Scientifically-Driven Clinical Development
THE POWER OFx Experts. Experience. Execution. A Deeper Dive into Psychiatry Incidences of mental disorders such as depression, bipolar, anxiety disorders, and schizophrenia continue to grow around the
More informationRFL Team Engagement Strategy. Healthcare
RFL Team Engagement Strategy Healthcare Benefits of RFL/Healthcare Partnership There is a natural existing partnership between the healthcare community and the American Cancer Society. Both share in the
More informationTranslational Cardiac Stem Cell Program ( TCSCP )
Translational Cardiac Stem Cell Program ( TCSCP ) 2017 Developing Revolutionary Treatments for Multiple Diseases Dr. Yerem founded the TCSCP in 2003 to develop revolutionary treatments for life threatening
More informationOn behalf of the Infectious Diseases Society of America (IDSA), I am pleased to provide
Transmitted by Jonathan Nurse, Director of Government Relations, IDSA The Infectious Diseases Society of America s (IDSA) Fiscal Year 2015 Funding Statement Submitted to the House Appropriations Subcommittee
More informationEmergency Plan. Pink Ribbon Red. under President. With. screened and Significantly. Commitments: to catalyze. a dynamic, including. of shared.
Pink Ribbon Red Ribbon Overview Pink Ribbon Red Ribbon is an innovative partnership to leverage public and private investments in global health to combat cervical and breast cancer two of the leading causes
More informationOHSU Knight Cancer Institute Overview and Update
OHSU Knight Cancer Institute Overview and Update for Senate Health Care and Human Services Committee Steve Stadum, COO, OHSU Knight Cancer Institute September 15, 2014 Presentation Brief Overview of OHSU
More informationMr. Kevin Dwan. The Sabrina Foundation Center for Cardiovascular Health in Pregnancy
A Proposal to Mr. Kevin Dwan For support of The Sabrina Foundation Center for Cardiovascular Health in Pregnancy A Proposal for the Support of The Sabrina Foundation Center for Cardiovascular Health in
More informationANNUAL REPORT 2014 FINDING CONNECTIONS FINDING A CURE
ANNUAL REPORT 2014 FINDING CONNECTIONS FINDING A CURE FEBRUARY 1, 2013 TO JANUARY 31, 2014 MESSAGE FROM OUR LEADERSHIP For all of us, motor neurons, and the connections they make between the brain and
More informationAn Extraordinary Resource for Cancer Care
An Extraordinary Resource for Cancer Care Anderson Family Cancer Institute The Campaign for Jupiter Medical Center Gaining Critical Mass Against Cancer $50 Million fundraising goal to build our new cancer
More informationMelanoma Research Alliance-Pfizer Academic-Industry Partnership Awards
Melanoma Research Alliance-Pfizer Academic-Industry Partnership Awards Wendy K.D. Selig, President & CEO, MRA Julia Perkins, M.D. Medical Director, Oncology, Pfizer Melanoma Research Alliance Mission:
More informationREPORT TO CONGRESS Multi-Disciplinary Brain Research and Data Sharing Efforts September 2013 The estimated cost of report or study for the Department of Defense is approximately $2,540 for the 2013 Fiscal
More informationtransforming cancer care Yale Cancer Center
transforming cancer care Yale Cancer Center At its heart, cancer is a disease a ecting families families that support patients, in the hospital and at home. Thomas J. Lynch, Jr. 82, 86 m.d. Director,
More informationMaking a Difference. Highest quality care. Education. Research. Innovation. OUR MISSION:
Making a Difference Highest quality care. Education. Research. Innovation. OUR MISSION: To deliver world-class care on a daily basis to our patients using the most advanced technologies available. To conduct
More informationBACK TO SPINAL RESEARCH
Dr. Phil Switzer Clinical Professor, Department of Radiology, UBC and Managing Radiologist, Greig Associates X-Ray, BMD, Ultrasound, Mammography to be honoured by The University of British Columbia, The
More informationYale Center For Clinical Investigation. Internship Program. Join Our Growing Team and Help Us Discover. Yale
Center For Clinical Investigation Internship Program Join Our Growing Team and Help Us Discover Moving Science Forward Local teens take the artificial pancreas for a test run at City Climb Gym in New Haven.
More informationWHF Salim Yusuf Emerging Leaders Programme
WHF Salim Yusuf Emerging Leaders Programme Empowering the next generation of leaders to shape the future of cardiovascular health www.whfel.org Investing in the CVD leadership of the future The World Heart
More informationannual report
2010-11 annual report A year in motion Annual Report From the director The past year has been one of substantial achievement for the Virginia Commonwealth University Parkinson s Disease Center. As a result
More informationPosition Profile Chief Executive Officer Feeding America San Diego San Diego, CA
Position Profile Chief Executive Officer Feeding America San Diego San Diego, CA Feeding America San Diego is seeking an experienced and inspirational Chief Executive Officer to lead this impactful and
More informationThe Reimagining Health Collaborative 2017: The Church and Mental Health
The Reimagining Health Collaborative 2017: The Church and Mental Health Do you or others in your congregation live with mental illness? Does your congregation long to promote mental health and to respond
More informationMore active. More productive.
More active. More productive. PARTICIPACTION S 2018 PRE-BUDGET SUBMISSION TO THE HOUSE OF COMMONS STANDING COMMITTEE ON FINANCE Elio Antunes, President & CEO PARTICIPACTION 77 BLOOR STREET W, SUITE 2015,
More informationAustralasian Sleep Association
Australasian Sleep Association Submission to The Government s Review Panel Mr Simon McKeon, Prof. Henry Brodaty AO, Prof. Ian Frazer, Prof. Melissa Little, Ms Elizabeth Alexander AM and Mr Bill Ferris
More informationTestimony of the Association for Professionals in Infection Control and Epidemiology (APIC) and
Testimony of the Association for Professionals in Infection Control and Epidemiology (APIC) and The Society for Healthcare Epidemiology of America (SHEA) to the U.S. House of Representatives Appropriations
More informationNIH FY 2017 Budget Roll-Out Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health February 9, 2016
NIH FY 2017 Budget Roll-Out Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health February 9, 2016 NIH s FY 2017 Budget Request Year FY 2015 FY 2016 FY 2017 Request Program Level ($B)
More informationPatrons. For further information please visit
For further information please visit www.uea.ac.uk/boneandjoint Patrons Henry Cator OBE FRICS DL Ms Caroline Jarrold Mark Jeffries Richard Jewson JP MA Hon.DCL Viscountess Knollys OBE DL Norfolk Bone
More informationProgram Priorities 2018
Program Priorities 2018 Blank Page 2 CONTENTS: About CPRIT Program Priorities Project...Page 5 Process to Develop Program Priorities...Page 6 Scope of Program Priorities Project...Page 6 CPRIT s Long-Term
More informationPROGRESS UPDATE. The Pan-Mass Challenge
PROGRESS UPDATE The Pan-Mass Challenge Fall 2017 PAN-MASS CHALLENGE: HITTING A HIGHER GEAR IN THE FIGHT AGAINST CANCER For nearly four decades, the Pan-Mass Challenge (PMC) and Dana- Farber Cancer Institute
More informationChampioning patients every step of the way
Championing patients every step of the way The majority of people living with a rare disease have no treatment for their condition. At Shire, we have long believed we have a unique opportunity to champion
More informationHVTN 505 Study HIV Vaccine Candidate Not Effective
Subscribe Unsubscribe HVTN 505 Study HIV Vaccine Candidate Not Effective The National Institute of Allergy and Infectious Diseases (NIAID) and the HIV Vaccine Trials Network have announced there will be
More informationCANCER 1.7 M 609,000 26% 15.5 M 73% JUST THE FACTS. More Than 1,100 Cancer Treatments in Clinical Testing Offer Hope to Patients
CANCER MEDICINES IN DEVELOPMENT 2018 REPORT JUST THE FACTS MORE THAN 1.7 M ESTIMATED NEW CASES OF CANCER IN 2018 IN THE UNITED STATES MORE THAN 609,000 U.S. CANCER DEATHS ARE EXPECTED IN 2018 SINCE PEAKING
More informationUnited Way Campaign s
United Way Campaign Emails This document contains email messaging for your United Way of Greater St. Louis Campaign. You will find 2 Kickoff emails and 7 Reminder emails to choose from. When sending through
More informationNEUROSCIENCE. THE POWER OFx. Experts. Experience. Execution. A Deeper Dive into Neurology. Scientifically-Driven Clinical Development
THE POWER OFx Experts. Experience. Execution. A Deeper Dive into Neurology Medpace supports our sponsors who are advancing new neurological products by providing specialized expertise in the design and
More informationCEO Operational Report. Annual General Meeting 23 October 2013
CEO Operational Report Annual General Meeting 23 October 2013 Leading the Field Clinical Trials Axon Sports Cogstate Research COGNIGRAM Playing an integral role in cognition-related clinical trials Cutting
More information2017 Strategic Plan. Icahn School of Medicine at Mount Sinai. Dennis S. Charney, MD
Icahn School of Medicine at Mount Sinai 2017 Strategic Plan Dennis S. Charney, MD Strategic Plan 2006 A Success Story How Did We Achieve Success? 1. Established world-class interdepartmental, multi-disciplinary
More informationLucille Beck, PhD Chief Consultant, Rehabilitation and Prosthetic Services Veterans Health Administration Department of Veterans Affairs
How to Facilitate Rehabilitation Care Lucille Beck, PhD Chief Consultant, Rehabilitation and Prosthetic Services Veterans Health Administration Department of Veterans Affairs The only victor in war is
More informationRAPID DIAGNOSIS AND TREATMENT OF MDR-TB
RAPID DIAGNOSIS AND TREATMENT OF MDR-TB FORMING PARTNERSHIPS TO STRENGTHEN THE GLOBAL RESPONSE TO MDR-TB - WHERE IT MATTERS MOST I am delighted that this initiative will improve both the technology needed
More informationUnited Way 2017 Campaign s
United Way 2017 Campaign Emails This document contains email messaging for your United Way of Greater St. Louis Campaign. You will find 1 pre-kickoff email, 2 kickoff emails, 4 reminder emails, and a variety
More informationPROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund
PROGRESS UPDATE Evan T. Mandeville DIPG Research Fund December 2018 EXECUTIVE SUMMARY As a top-ranked pediatric cancer center, Dana-Farber Cancer Institute combines first-rate patient care with groundbreaking
More informationProgress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader:
SU2C -Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition Dream Team Translational Research Grant: DNA Repair Therapies for Ovarian Cancer AND SU2C Catalyst Merck-Supported Supplemental
More informationONLY AT NYSCF Stem Cells in the City Sponsorship Offering
ONLY AT NYSCF The New York Stem Cell Foundation (NYSCF) accelerates cures and better treatments for patients through stem cell research. The NYSCF global community includes over 140 researchers at leading
More informationACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology
ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology ACGME approved: June 27, 2006; effective: July 1, 2007 ACGME approved focused revision: September 30, 2012; effective:
More informationGiving Opportunities Center for Regenerative Medicine $5 million
Beyond Extraordinary Giving Opportunities Name Center for Regenerative Medicine Leukemia Center of Excellence Lymphoma Center of Excellence Multiple Myeloma Center of Excellence The Infusion Treatment
More informationSuraj Madoori, Treatment Action Group, U.S. and Global Health Policy Director. On behalf of the Tuberculosis Roundtable
United States House of Representatives Committee on Appropriations Subcommittee on State and Foreign Operations and Related Programs Fiscal Year 2020 Written Testimony Suraj Madoori, Treatment Action Group,
More informationYMCA of Niagara Strategic Plan ymcaofniagara.org
YMCA of Niagara Strategic Plan 2016-2019 ymcaofniagara.org Table of Contents Our YMCA Today... 3 The Time Is Now... 4 The Canada We Want... 5 The Road Ahead... 5 The YMCA We Need... 5 Our Commitment...
More informationJohns Hopkins CONQUEST AN UPDATE FROM THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER ON ITS MARYLAND CIGARETTE RESTITUTION FUNDS 2011
Johns Hopkins CONQUEST AN UPDATE FROM THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER ON ITS MARYLAND CIGARETTE RESTITUTION FUNDS 2011 A Note from the Director This is truly an exciting time to be a part
More informationSponsorship Opportunities I AM A RIDER. I AM THE DIFFERENCE. Hosted by. October 29, 2017
Sponsorship Opportunities I AM A RIDER. I AM THE DIFFERENCE. Hosted by October 29, 2017 Be a part of the 2017 Wheel to Survive Houston Wheel to Survive 2017 is Houston s second annual indoor cycling fundraiser
More informationRESEARCH EDUCATION COMMUNITY STRATEGIC PLAN
RESEARCH EDUCATION COMMUNITY STRATEGIC PLAN 2016-2021 VISION Leading the improvement of musculoskeletal health for patients across their lifespan through research and education. MISSION To enhance the
More informationDIVISION OF NEPHROLOGY & HYPERTENSION
DIVISION OF NEPHROLOGY & HYPERTENSION DIVISION OF NEPHROLOGY & HYPERTENSION UH CASE MEDICAL CENTER Among the nation s leading academic medical centers, UH Case Medical Center is the primary affiliate of
More information